Neurology
Clinically Isolated Syndrome (CIS) Risk of MS
Estimates risk of conversion from clinically isolated syndrome (CIS) to clinically definite multiple sclerosis (CDMS) based on MRI and clinical features.
References
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Drugs
- Cladribine · Multiple Sclerosis — Disease-Modifying Therapy
- Aciclovir 800mg Tablets (Ramsay Hunt Syndrome / Herpes Zoster Oticus) · Antiviral — nucleoside analogue (herpes zoster treatment)
- Pramipexole (Restless Legs Syndrome — Elderly) · Dopamine Agonist (D2/D3 Receptor)
- Topiramate · Anticonvulsant (Multiple Mechanisms)
- Zonisamide · Antiepileptic — Multiple Mechanisms
- Prednisolone (Paediatric) · Corticosteroid — Asthma Exacerbation / Croup / Nephrotic Syndrome / IBD
Pathways
- Acute Stroke / TIA Assessment · NICE NG128; RCP Stroke Guidelines 2023
- Status Epilepticus (Adults) · NICE CG137; ESEM guidelines; RCP Neurology Guidelines
- Suspected Subarachnoid Haemorrhage · NICE NG228; RCEM 2023; AHA/ASA 2023
- Adult Head Injury · NICE NG232 (2023)
- Bell's Palsy / Facial Nerve Palsy · ENT UK 2017; AAN
- Vertigo Workup · ENT UK; NICE CKS
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.
